1057652-85-3

Upstream product

• 72922-60-2 methyl 3-amino-4-methyl-5-nitrobenzoate 
• 16533-71-4 3,5-dinitro-p-toluic acid 
• 49592-71-4 methyl 4-methyl-3,5-dinitrobenzoate 
• 1057652-84-2 methyl 3-chloro-4-methyl-5-nitrobenzoate 

Downstream Products

• 1070886-77-9 C₁₁H₁₀ClNO₆ 
• 1070886-78-0 C₁₇H₁₄Cl₂N₂O₅ 
• 1070886-79-1 C₁₇H₁₆Cl₂N₂O₃ 
• 1070885-59-4 C₂₇H₂₈Cl₂N₄O₄S 
• 1070886-45-1 C₁₂H₁₀ClNO₈ 
• 1070886-33-7 C₂₆H₂₆Cl₂N₄O₄S 
• 1070886-76-8 C₂₀H₂₆ClNO₈ 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUND

Provided is a compound having a superior FLAP inhibitory action and useful as a prophylactic or therapeutic agent for arteriosclerosis and the like, and a salt thereof. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present DESCRIPTION, or a salt thereof.

Orally active zwitterionic factor Xa inhibitors with long duration of action

We have optimized 2-aminomethylphenylamine derivative as a factor Xa inhibitor. Several polar functional groups were introduced in the central phenyl ring, and we focused on zwitter ionic compound showing continuous inhibitory activity in oral administrat